EPA policy on clean air and climate
TB control policy
CMS policy
Research funding
tobacco control policies
VA research funding
Duration: January 1, 2008
to
present
General Issues: Clean Air & Water (Quality) , Health Issues , Tobacco , Veterans , Foreign Relations , Environmental/Superfund , Medical/Disease Research/Clinical Labs
Spending: about $8,249,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Environmental Protection Agency (EPA), Centers For Medicare and Medicaid Services (CMS), Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA), U.S. Agency for International Development (USAID), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on May 8.
Original Filing: 301578966.xml
Lobbying Issues
EPA policy on clean air and climate
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
TB control policy
CMS policy
Research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Agencies Lobbied
Veterans Affairs - Dept of (VA) U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Feb. 6.
Original Filing: 301543549.xml
Lobbying Issues
EPA policy on clean air and climate
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
TB control policy
USPSTF policy
CMS policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
3rd Quarter, 2023
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Nov. 20, 2023.
Original Filing: 301519226.xml
Lobbying Issues
EPA policy on clean air and climate
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
TB control policy
USPSTF policy
CMS policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
2nd Quarter, 2023
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Sept. 8, 2023.
Original Filing: 301496130.xml
Lobbying Issues
EPA policy on clean air and climate
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
TB control policy
USPSTF policy
CMS policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
1st Quarter, 2023
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301464631.xml
Lobbying Issues
EPA policy on clean air and climate
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
TB control policy
USPSTF policy
CMS policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
4th Quarter, 2022
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 30, 2023.
Original Filing: 301445305.xml
Lobbying Issues
Clean Air Act
Inflation Reduction Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
Fy23 health appropriations
budget reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FDA authority to regulate tobacco products
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
3rd Quarter, 2022
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301420154.xml
Lobbying Issues
Clean Air Act
Inflation Reduction Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
Fy23 health appropriations
budget reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FDA authority to regulate tobacco products
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
2nd Quarter, 2022
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 31, 2022.
Original Filing: 301399740.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
Fy23 health appropriations
budget reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FDA authority to regulate tobacco products
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
1st Quarter, 2022
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 31, 2022.
Original Filing: 301399743.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
international tb funding - State-Foreign Operations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
va medical and prosthetics research program - Military Construction-Veterans Affairs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
research and public health funding Labor-HHS-Education
budget reconciliation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2021
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 21, 2022.
Original Filing: 301339146.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
international tb funding - State-Foreign Operations
H.R. 4373
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
tobacco control
s1314 tobacco tax equity act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
va medical and prosthetics research program - Military Construction-Veterans Affairs
H.R. 4355
S. 2604
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
research and public health funding Labor-HHS-Education
H.R. 4502
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2021
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301303591.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
international tb funding - State-Foreign Operations
H.R. 4373
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
tobacco control
s1314 tobacco tax equity act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
va medical and prosthetics research program - Military Construction-Veterans Affairs
H.R. 4355
S. 2604
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
research and public health funding Labor-HHS-Education
H.R. 4502
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2021
AMERICAN THORACIC SOCIETY amended a lobbying report for in-house lobbying in Q32021 on Oct. 19, 2021
Original Filing: 301304273.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
international tb funding - State-Foreign Operations
H.R. 4373
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
tobacco control
s1314 tobacco tax equity act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
va medical and prosthetics research program - Military Construction-Veterans Affairs
H.R. 4355
S. 2604
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
research and public health funding Labor-HHS-Education
H.R. 4502
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2021
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 14, 2021.
Original Filing: 301275862.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
funding for va medical and prosthetics research program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
research and public health funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2021
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on May 10, 2021.
Original Filing: 301270815.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
funding for va medical and prosthetics research program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
research and public health funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2020
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Feb. 16, 2021.
Original Filing: 301248441.xml
Lobbying Issues
FY2021 Interior-Environment appropriations - EPA funding and Clean Air Policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2021 State-Foreign Operations appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY21 Agriculture Appropriation bill
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
FY 21 Mil/Con/VA Appropriations bill - VA research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
COVID supplemental legislation
Fy2021 Labor-HHS appropriations - NIH, CDC, HRSA funding and policy
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2020
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Nov. 13, 2020.
Original Filing: 301226557.xml
Lobbying Issues
FY2021 Interior-Environment appropriations - EPA funding and Clean Air Policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2021 State-Foreign Operations appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY21 Agriculture Appropriation bill
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
FY 21 Mil/Con/VA Appropriations bill - VA research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
COVID supplemental legislation
Fy2021 Labor-HHS appropriations - NIH, CDC, HRSA funding and policy
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2020
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 26, 2020.
Original Filing: 301205726.xml
Lobbying Issues
FY2021 Interior-Environment appropriations - EPA funding and Clean Air Policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2021 State-Foreign Operations appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY21 Agriculture Appropriation bill
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
FY 21 Mil/Con/VA Appropriations bill - VA research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
COVID supplemental legislation
Fy2021 Labor-HHS appropriations - NIH, CDC, HRSA funding and policy
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2020
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 26, 2020.
Original Filing: 301205727.xml
Lobbying Issues
FY2021 Interior-Environment appropriations - EPA funding and Clean Air Policy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2021 State-Foreign Operations appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY21 Agriculture Appropriation bill
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
FY 21 Mil/Con/VA Appropriations bill - VA research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
COVID supplemental legislation
Fy2021 Labor-HHS appropriations - NIH, CDC, HRSA funding and policy
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2020
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on June 2, 2020.
Original Filing: 301183960.xml
Lobbying Issues
FY20 Interior/Environment Appropriations bill (H.R.3052/S2580)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY20 State/Foreign Operations Approprations bill (H.R.2839/S2583)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY20 Agriculture Appropriation bill (HR3164/S2522)
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
S.1541/H.R.2411, S2158, S1541, HR2339, S655, HR1498
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 20 Mil/Con/VA Appropriations bill (H.R.2745)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. 834/H.R. 3080, the Comprehensive TB Elimination Act
H.R. 2781, included pediatric subspecialty loan repayment program
HR2740 LHHS FY20
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2019
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Feb. 19, 2020.
Original Filing: 301141959.xml
Lobbying Issues
FY20 Interior/Environment Appropriations bill (H.R.3052/S2580)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY20 State/Foreign Operations Approprations bill (H.R.2839/S2583)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY20 Agriculture Appropriation bill (HR3164/S2522)
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
S.1541/H.R.2411, S2158, S1541, HR2339, S655, HR1498
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 20 Mil/Con/VA Appropriations bill (H.R.2745)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. 834/H.R. 3080, the Comprehensive TB Elimination Act
H.R. 2781, included pediatric subspecialty loan repayment program
HR2740 LHHS FY20
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2019
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Nov. 1, 2019.
Original Filing: 301080708.xml
Lobbying Issues
FY20 Interior/Environment Appropriations bill (H.R.3052/S2580)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY20 State/Foreign Operations Approprations bill (H.R.2839/S2583)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY20 Agriculture Appropriation bill (HR3164/S2522)
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
S.1541/H.R.2411, S2158, S1541, HR2339, S655, HR1498
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 20 Mil/Con/VA Appropriations bill (H.R.2745)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. 834/H.R. 3080, the Comprehensive TB Elimination Act
H.R. 2781, included pediatric subspecialty loan repayment program
HR2740 LHHS FY20
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2019
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Sept. 9, 2019.
Original Filing: 301061964.xml
Lobbying Issues
FY20 Interior/Environment Appropriations bill (H.R.3052)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY20 State/Foreign Operations Approprations bill (H.R.2839)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY20 Agriculture Appropriation bill (no bill number)
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
S.1541/H.R. 2411, Tobacco to 21 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 20 Mil/Con/VA Appropriations bill (H.R.2745)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. 834/H.R. 3080, the Comprehensive TB Elimination Act
H.R. 2781, included pediatric subspecialty loan repayment program
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2019
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on June 5, 2019.
Original Filing: 301041854.xml
Lobbying Issues
FY20 Interior/Environment Appropriations bill (H.R.3052)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY20 State/Foreign Operations Approprations bill (H.R.2839)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY20 Agriculture Appropriation bill (no bill number)
S.9 Traditional Cigar Manufacture and Jobs Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 20 Mil/Con/VA Appropriations bill (H.R.2745)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301015706.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
HR 2235/S. 428 ACE Kids Act
S. 3029 PREEMIE Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
HR 350/S.203 RPM Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 26, 2018.
Original Filing: 300999395.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
HR 350/S.203 RPM Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 24, 2018.
Original Filing: 300981241.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
HR 350/S.203 RPM Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on May 31, 2018.
Original Filing: 300960874.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
Better Care Reconciliation Act
Bipartisan Healthcare Stabilization Act
Tax Cuts and Jobs Act, H.R. 1
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
HR 350/S.203 RPM Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 23, 2018.
Original Filing: 300937837.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
American Health Care Act, H.R. 1628
Better Care Reconciliation Act
Bipartisan Healthcare Stabilization Act
Tax Cuts and Jobs Act, H.R. 1
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
HR 350/S.203 RPM Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1279/S 319, Helping Veterans Exposed to Burn Pits Act
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 19, 2017.
Original Filing: 300909630.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
American Health Care Act, H.R. 1628
Better Care Reconciliation Act
Ensuring Childrens Access to Specialty Care Act of 2017 H.R. 564/S. 294
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1279/S 319, Helping Veterans Exposed to Burn Pits Act
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 21, 2017.
Original Filing: 300897934.xml
Lobbying Issues
FY2018 Labor-HHS-ED Appropriations
American Health Care Act, H.R. 1628
Better Care Reconciliation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2018 Interior-Environment Appropriations
HR806 Smoggy Skies/Ozone Standards Implementation Act
HR 1430 Honest and Open New EPA Science Treatment Act
HR 1431 EPA Science Advisory Board Reform Act of 2017
S. 263 - Ozone Standards Implementation Act &
S. 452 - Ozone Regulatory Delay and Extension of Assessment Length (ORDEAL) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2018 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 564/S. 294, cigar bill
HR 1136 FDA tobacco regulatory clarification act
HR 3268 FY18 Agriculture/FDA appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1279/S 319, Helping Veterans Exposed to Burn Pits Act
HR 2998/S 1557 FY18 Mil/Con Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on May 8, 2017.
Original Filing: 300879890.xml
Lobbying Issues
FY2017 labor-HHS Appropriations
H.R. 1628 American Health Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
EPA-Interior-Environment Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2017 Foreign Ops appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 564/S. 294, cigar bill
H.R. 1136 FDA tobacco regulatory clarification act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 1279/S. 319, Helping Veterans Exposed to Burn Pits Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 23, 2017.
Original Filing: 300855284.xml
Lobbying Issues
FY2017 Labor-HHS Appropriations hr 5926/s3040
FY2017 FDA-Agriculture Appropriations
S. 185, PATH Act
S. 1878 Advancing Hope Act of 2016 (pediatric disease PRV extension)
H.R. 1850/S. 2782 Ensuring Children's Access to Specialty Care
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2017 Interior-Env. Appropriations H.R.5538/S.3068
S. 2882 Ozone Standards Implementation Act of 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2017 Foreign Ops Appropriations H.R.5912/S.3117 - international TB Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
FY2017 FDA-Agriculture Appropriations H.r 5054/S.2956
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR2237/S2679 Helping Veterans Exposed to Burn Pits Act
FY17 Mil/Con Appropriations bill H.R. 5325/S.2806
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 19, 2016.
Original Filing: 300832153.xml
Lobbying Issues
FY2017 Labor-HHS Appropriations hr 5926/s3040
FY2017 FDA-Agriculture Appropriations
S. 185, PATH Act
S. 1878 Advancing Hope Act of 2016 (pediatric disease PRV extension)
H.R. 1850/S. 2782 Ensuring Children's Access to Specialty Care
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2017 Interior-Env. Appropriations H.R.5538/S.3068
S. 2882 Ozone Standards Implementation Act of 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2017 Foreign Ops Appropriations H.R.5912/S.3117 - international TB Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
FY2017 FDA-Agriculture Appropriations H.r 5054/S.2956
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR2237/S2679 Helping Veterans Exposed to Burn Pits Act
FY17 Mil/Con Appropriations bill H.R. 5325/S.2806
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 20, 2016.
Original Filing: 300819125.xml
Lobbying Issues
FY17 LHHS bill
FY17 Ag Bill
S. 185, Path Act
S. 2014/H.R. 3466 Next Generation Researchers Act
Ensuring Childrens Access to Specialty Care Act, H.R. 1859/S. 2782
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY17 Interior/EPA appropriations bill
S. 2072
S. 2882 Ozone Standards Implementation Act of 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY17 State-Foreign Operations Appropriations legislation international TB funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
FY17 Ag Approps bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR2237/S2679 Helping Veterans Exposed to Burn Pits Act
FY17 Mil/Con/VA Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 19, 2016.
Original Filing: 300796090.xml
Lobbying Issues
FY17 LHHS bill
FY17 Ag Bill
S. 185, Path Act
S. 2014/H.R. 3466 Next Generation Researchers Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY17 Mil/Con/VA bill - VA research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY17 State-Foreign Operations Appropriations legislation international TB funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
FY17 Ag Approps bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Hr 2237/S2679 Helping Veterans Exposed to Burn Pits Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300781384.xml
Lobbying Issues
FY2016 Labor-HHS & Ed Appropriations (HR 3020/S1695)
FY2016 State-Foreign Operations Appropriations legislation (HR 2772/S1725)
H.R. 6, 21st Century Cures Act
H.R. 2629, Antibiotic Development to Advance Patient Treatment Act
S. 185, PATH ACT antibiotic development
H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1030/S. 544 - Secret Science Reform Act
HR 1029/S. 543 - EPA Scientific Advisory Committee reform act
ORDEAL Act hr1327/S640
CASE act s751
Clean Air Strong Economies Act HR 1388
Fy2016 Interior-Environment Appropriations Legislation (RH2822/S1645)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2016 State-Foreign Operations Appropriations legislation (HR 2772/S1725) international TB funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
HR 3049/S 1800 FY16 Agriculture Approps bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 22, 2015.
Original Filing: 300766268.xml
Lobbying Issues
FY2016 Labor-HHS & Ed Appropriations (HR 3020/S1695)
FY2016 State-Foreign Operations Appropriations legislation (HR 2772/S1725)
H.R. 6, 21st Century Cures Act
H.R. 2629, Antibiotic Development to Advance Patient Treatment Act
S. 185, antibiotic development
H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1030/S. 544 - Secret Science Reform Act
HR 1029/S. 543 - EPA Scientific Advisory Committee reform act
ORDEAL Act hr1327/S640
CASE act s751
Clean Air Strong Economies Act HR 1388
Fy2016 Interior-Environment Appropriations Legislation (RH2822/S1645)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2016 State-Foreign Operations Appropriations legislation (HR 2772/S1725) international TB funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
HR 3049/S 1800 FY16 Agriculture Approps bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 20, 2015.
Original Filing: 300742548.xml
Lobbying Issues
FY2016 Labor-HHS & Ed Appropriations (HR 3020/S1695)
FY2016 State-Foreign Operations Appropriations legislation (HR 2772/S1725)
H.R. 6, 21st Century Cures Act
H.R. 2629, Antibiotic Development to Advance Patient Treatment Act
S. 185, antibiotic development
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1030/S. 544 - Secret Science Reform Act
HR 1029/S. 543 - EPA Scientific Advisory Committee reform act
ORDEAL Act hr1327/S640
CASE act s751
Clean Air Strong Economies Act HR 1388
Fy2016 Interior-Environment Appropriations Legislation (RH2822/S1645)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2016 State-Foreign Operations Appropriations legislation (HR 2772/S1725) international TB funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
HR 3049/S 1800 FY16 Agriculture Approps bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 29, 2015.
Original Filing: 300729083.xml
Lobbying Issues
NIH/CDC funding - FY16 LHHS bill
Promise for Antibiotics and Therapeutics for Health Act, S. 185
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1030/S. 544 - Secret Science Reform Act
HR 1029/S. 543 - EPA Scientific Advisory Committee reform act
2016 Interior-Environment Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
International TB funding - FY16 Foreign Operations Approps bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 662/S 441 Traditional Cigar bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
AMERICAN THORACIC SOCIETY amended a lobbying report for in-house lobbying in Q42014 on Jan. 23, 2015
Original Filing: 300709276.xml
Lobbying Issues
FY2015 Labor-HHS-ED Appropriations legislation
The Comprehensive TB Elimination Act, H.R. 5835
H.R. 3742 Antibiotic Development to Advance Patient Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2015 Interior-Environment Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2015 State Dept.-Foreign Operations Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 792, S. 772, Traditional and Premium Cigar Manufacturing and Small Business Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300704369.xml
Lobbying Issues
FY2015 Labor-HHS-ED Appropriations legislation
The Comprehensive TB Elimination Act, H.R. 5835
H.R. 3742 Antibiotic Development to Advance Patient Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY2015 Interior-Environment Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
FY2015 State Dept.-Foreign Operations Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 792, S. 772, Traditional and Premium Cigar Manufacturing and Small Business Preservation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300684618.xml
Lobbying Issues
Research funding, including;
FY15 LHHS Appropriations bill
FY15 Mil/Con/VA Appropriations bill HR4486
FY15 Interior/Environment bill HF5171
ADAPT Act, H.R. 3742
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Veterans Affairs - Dept of (VA)
Lobbying Issues
FY15 Interior/Environment Appropriations bill - HR5171
Various bill to impact EPA's authority to regulate air pollution
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 1, 2014.
Original Filing: 300671452.xml
Lobbying Issues
FY2015 Labor-HHS-ED Appropriations
FY2015 State-Foreign Operations Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY15 Mil/Con VA appropriations bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY15 Interior/Environment Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
H.R. 792/S. 772 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2014
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on May 5, 2014.
Original Filing: 300651168.xml
Lobbying Issues
FY15 Labor Health and Human Services Approps bill
Antibiotic Development to Advance Patient Treatment Act, H.R. 3742
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY15 Interior Enviroment Approps bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
Traditional and Premium Cigar Manufacturer and Small Business Preservation Act H.R. 792/S.772
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2015 State-Foreign Operations Appropriations - TB funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY15 Mil/Con/Veterans Affairs Bill - VA Research Funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 22, 2014.
Original Filing: 300627487.xml
Agencies Lobbied
U.S. House of Representatives U.S. Senate Environmental Protection Agency (EPA)
Lobbying Issues
HR 2855/S.1372 State Foreign Op bill - international TB funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
PREEMIE Reauthorization Act School Access to Emergency Epinephrine Act, H.R. 2094/S. 1503
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2013, H.R.792/S. 772
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 22, 2013.
Original Filing: 300607793.xml
Lobbying Issues
FY14 L-HHS (S.1284) - NIH and CDC funding
FY 4 Mil/Con (HR. 2216) - VA research funding
Foreign Ops (Hr 2855/S. 1372) - International TB funding
Cigar bill (H.R. 792/S 772)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH) Veterans Affairs - Dept of (VA) U.S. Agency for International Development (USAID)
Lobbying Issues
FY14 Interior/Environment (no bill number) - EPA funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate Environmental Protection Agency (EPA)
2nd Quarter, 2013
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 22, 2013.
Original Filing: 300583265.xml
Lobbying Issues
Traditional Cigar Bill HR 792/S 772
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
International TB funding - State Foreign Ops Appropriations bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
LHHS Appropriations bill
Pediatric Subspecialty and Mental Health Workforce Reauthorization Act, H.R. 1827
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 2, 2013.
Original Filing: 300568997.xml
Lobbying Issues
NIH and CDC funding
FY14 LHHS bill (no bill number)
Mil/Con Approps bill (HR 2216) - research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
State Foreign Ops bill - TB funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Traditional Cigar Bill - S. 72/HR 792
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2012
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 24, 2013.
Original Filing: 300543659.xml
Lobbying Issues
HR 2505/S1350 Pulmonary Fibrosis Research Enhancement Act
HR1810/S775 Pulmonary Hypertension Research and Education Act
FY12 LHHS bill
S1440 Preemie Reauthorization Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY12 Foreign Operations Bill - International TB funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2012
AMERICAN THORACIC SOCIETY amended a lobbying report for in-house lobbying in Q42012 on Jan. 24, 2013
Original Filing: 300543696.xml
Lobbying Issues
HR 2505/S1350 Pulmonary Fibrosis Research Enhancement Act
RH 1810/S775 Pulmonary Fibrosis Research and Education Act
FY13 LHHS bill
S1440 Preemie Reauthorization Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY13 Foreign Operations Appropriations Bill - international TB funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 22, 2012.
Original Filing: 300520801.xml
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
NIH, CDC funding
HR 6190
Budget Sequestration
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
EPA funding/Clean Air Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Environmental Protection Agency (EPA)
Lobbying Issues
International TB control funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 19, 2012.
Original Filing: 300490879.xml
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY13 L-HHS Appropriations
FY 13 Mil/Con/VA Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2012
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 23, 2012.
Original Filing: 300475985.xml
Lobbying Issues
FY2013 LHHS Bill - NIH funding, CDC funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2013 Interior/Environment Appropriations - EPA funding, NIEHS Superfund research funding
Sen. Inhofe Congressional Review Act resolution to block EPA Clean Air Act Rules
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2013 Foreign Operations bill - International TB control funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2011
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300449268.xml
Lobbying Issues
International TB funding
FY13 State/Foreign Operations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1633 Farm Dust Regulation Prevention Act; H.R. 2681, the Cement Sector Regulatory Relief Act of 2011;
HR 2250 EPA Regulatory Relief Act
HR 2401 Transparency in Regulatory Analysis of Impacts on the Nation Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2011
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 20, 2011.
Original Filing: 300424575.xml
Lobbying Issues
Foreign Ops Approprations - S.1601
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Clean Air Act/EPA authority
H.R. 2681, H.R. 2250, H.R. 2401
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Pulmonary Fibrosis Research Enhancement Act H.R. 2250/S.1350
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2011
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 19, 2011.
Original Filing: 300395622.xml
Lobbying Issues
Researching Funding
LHHS Appropriations Bill (no bill number yet)
Mil/Con/VA Appropriations bill (HR 2055)
Interior/EPA Appropriations bill (no bill number yet)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
International TB funding
State/Foreign Ops Appropriations (no bill number yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2011
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 21, 2010.
Original Filing: 300304203.xml
Lobbying Issues
Research Funding - FY11 LHHS Bill, FY11 Mil/Con/VA bill, FY11 Foreign Ops bill, FY11 Interior/Environment bill, Hr 1581/S1020 - Patient Focussed Critical Care Act, SRes 1122/H Res 432 - Year of the Lung Resolution
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH) Veterans Affairs - Dept of (VA)
1st Quarter, 2011
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 21, 2011.
Original Filing: 300380713.xml
Lobbying Issues
HR 1 - protect research and public health funding
HR 1473 - FY2011 Appropriations
HR2 /S192 - Repeal Job Killing Health-Care Law Act
H Res 276 - Comending Progress Made by Anti-TB programs
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1 - preserve EPA authority under the Clean Air Act
S493 - Small Business bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2010
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 25, 2011.
Original Filing: 300356002.xml
Lobbying Issues
FY11 L-HHS bill (NIH, CDC funding)
Year of the Lung Resolution (S.Res 432/H.Res 1122)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY11 Mil/Con-Veterans Affairs Appropriations (VA research funding)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY11 Interior/Environment (EPA funding)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 28, 2010.
Original Filing: 300331098.xml
Lobbying Issues
Research Funding - FY11 LHHS Bill, FY11 Mil/Con/VA bill, FY11 Foreign Ops bill, FY11 Interior/Environment bill, Hr 1581/S1020 - Patient Focussed Critical Care Act, SRes 1122/H Res 432 - Year of the Lung Resolution
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Aug. 3, 2010.
Original Filing: 300306106.xml
Lobbying Issues
Research Funding - FY11 LHHS Bill, FY11 Mil/Con/VA bill, FY11 Foreign Ops bill, FY11 Interior/Environment bill, Hr 1581/S1020 - Patient Focussed Critical Care Act, SRes 1122/H Res 432 - Year of the Lung Resolution
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH) Veterans Affairs - Dept of (VA)
1st Quarter, 2010
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 28, 2010.
Original Filing: 300277772.xml
Lobbying Issues
HR2996 Interior/Enviromental Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
HR 3293 LHHS Appropriations
HR 3082 Military Construction/VA Approprations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 3081 State/Foreign Operations Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2009
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300247354.xml
Lobbying Issues
HR2996 Interior/Environment Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Clean Air & Water (Quality)
Lobbying Issues
HR3293 LHHS Appropriations
HR3082/S1402 Military/VA Appropriations
HR3288 Consolidated Appropriations Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR3081/S1434 State/Foreign Operations Appropriation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2009
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300216852.xml
Lobbying Issues
FY10 State/Foreign Ops (HR 3081/S 1434)
FY10 Interior/Enviorment (HR 2892/S 1298)
FY10 Labor, HHS and Education (HR 3293)
FY10 Military/VA (HR3082/S 1407)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300188073.xml
Lobbying Issues
FY2010 LHHS bill - research & public health funding
FY2010 Mil/Con (H.R. 3082/S. 1407)- VA bill - research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2010 Foreign Operations Appropriations bill(HR 3081/S.1434) - TB funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2010 Interior/Environment Appropriations bill (H.R. 2996) -EPA research and enforcement funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300158461.xml
Lobbying Issues
HR 1105 - FY09 Omnibus Appropriations
HR 1 - American Recovery and Reinvestement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300131868.xml
Lobbying Issues
FY09 Appropriations bills
L-HHS
Mil/Con
Interior
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300102606.xml
Lobbying Issues
Medicare Coverage of Pulmonary Rehabilitation - HR 552/S. 329
Physicians Supply - HR 3886/S 718
Medicare SGR payments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
International TB funding S. 3288
Agencies Lobbied
U.S. House of Representatives U.S. Senate U.S. Agency for International Development (USAID)
Lobbying Issues
Research Funding HHS - HR 3230/HR 2638
Research Funding VA - HR 6599/S 3301
Agencies Lobbied
U.S. House of Representatives U.S. Senate Natl Institutes of Health (NIH) Veterans Affairs - Dept of (VA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA Tobacco bill - HR 1108/S 625
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Clean Air Act funding and enforcement
Agencies Lobbied
U.S. House of Representatives U.S. Senate Environmental Protection Agency (EPA)
2nd Quarter, 2008
In Q2, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on July 22, 2008.
Original Filing: 300083205.xml
Lobbying Issues
HR 6331 - Medicare Improvements for Patients and Providers Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY09 LHHS Appropriations Bill
Domestic TB Bill H.R. 1532/S/ 1551
International TB Bill H.R. 1567/S. 968
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY09 MilCon/VA Appropriations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY09 Interior/EPA Appropriations Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate Environmental Protection Agency (EPA)
1st Quarter, 2008
AMERICAN THORACIC SOCIETY amended a lobbying report for in-house lobbying in Q12008 on Sept. 9, 2010
Original Filing: 300307542.xml
Lobbying Issues
TB Control Legislation
Pulmonary Rehabilitation
Medicare Physician Reimbursement
Physician Supply Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
NIH, CDC, VA Research Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA) Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA authority to regulate tobacco
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Clean Air Act
EPA NAAQS for ozone
Agencies Lobbied
U.S. House of Representatives U.S. Senate Environmental Protection Agency (EPA)
1st Quarter, 2008
In Q1, AMERICAN THORACIC SOCIETY had in-house lobbyists. The report was filed on April 17, 2008.
Original Filing: 300041595.xml
Lobbying Issues
TB Control Legislation
Pulmonary Rehabilitation Legislation
Medicare Physician Reimbursement
Physician Supply Legislation
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC)
Agencies Lobbied
U.S. House of Representatives U.S. Senate U.S. Agency for International Development (USAID)
Lobbying Issues
NIH, CDC and VA research and public health funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA) Centers For Disease Control & Prevention (CDC) Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA authority to regulate tobacco legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Clean Air Act
EPA NAAQS for ozone
Agencies Lobbied
U.S. House of Representatives U.S. Senate Environmental Protection Agency (EPA)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate